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Abstract
Background: Vaginitis is the most common gynecological problem and the second most common infection. This condition occurs
in approximately 90% of the affected females; secondary to bacterial vaginosis and vulvovaginal candidiasis.
Objectives: According to the high prevalence of vulvovaginal candidiasis in Iran and because of the importance of controlling
causing species, the current study aimed to evaluate the prevalence of symptomatic vaginal candidiasis among females referred to
the hospitals affiliated to Shahid Beheshti University in Tehran, Iran in 2014.
Patients and Methods: In this cross-sectional study, 580 females suspected of vulvovaginal candidiasis were selected by simple
random sampling. In lithotomy position and after using sterile speculum without lubrication a fluid sample was obtained from
the upper part of the lateral wall of the vagina and the samples were cultured on agar medium. All samples were examined by the
same gynecologist.
Results: The prevalence of vaginal candidiasis was 15.5% and Candida albicans was observed in 92.3% of the subjects.
Conclusions: Candida albicans was the most common cause of vaginal candidiasis.
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1. Background
Vaginitis is the most common gynecological problem
and the second most common infection (1-3). This condi-
tion occurs in approximately 90% of affected females; sec-
ondary to bacterial vaginosis and vulvovaginal candidiasis
(4). Seventy five percent of females experience vulvovagi-
nal candidiasis at least once in their life (5, 6).
Candida albicans is the most common cause of mycotic
vaginitis in 80% -90% of symptomatic cases (7). Tendency
to relapse and the difficulty to control the recurrent infec-
tion make infection caused by these fungi a serious prob-
lem (8).
It seems that hormones have a prominent role in can-
didiasis, because the infection is observed before menar-
che and rarely after menopause (9) and the highest inci-
dence of the disease occurs in females aged 25-35 years.
Studies reported the high the prevalence of vulvovaginal
candidiasis in Iran (10). But there is no study on the preva-
lence of various forms of the disease in this region.
2. Objectives
The current study aimed to assess the prevalence of
vaginitis in females referred to the hospitals affiliated to
Shahid Beheshti University in Tehran, Iran in 2014.
3. Patients andMethods
This cross-sectional study was conducted in the hos-
pitals affiliated to Shahid Beheshti University in Tehran,
Iran, in 2014. After receiving the ethics approval and pa-
tients‘ informed consent, 580 females with itching, abnor-
mal vaginal secretion and one of the following symptoms
were selected by simple random sampling: dysuria, pH <
5.4, dyspareunia, vulvar erythema. Patients were enrolled
in the study based on positive dextrose agar testing result.
Patients aged 18 - 45 years, one sexual partner, vulvovagi-
nal candidiasis confirmed by clinical symptoms and posi-
tive KOH testing result were recruited. Females with preg-
nancy, history of vaginal medication, using antibiotics and
immunosuppressive drugs, use of exogenous hormones
included oral contraceptives within two weeks before the
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evaluation, vaginal intercourse in the last 24 hours, dia-
betes and autoimmune disease were excluded from the
study.
For sampling, patients were placed in lithotomy posi-
tion and after using sterile speculum without lubrication,
a fluid sample was obtained from the upper part of the lat-
eral wall of the vagina and placed on two slides and one
cultured on agar media. All samples were examined by
the same gynecologist. Samples were evaluated for Can-
dida spp. One to two drops of saline were added to the first
smear samples. Samples were excluded if there was a tri-
chomonia flagellated parasite. One drop of KOH 10% was
added to the second smear samples and the samples were
examined for Candida hyphae and amine odor. In the case
of bacterial vaginosis, the sample was excluded. Germ tube
test (germ tube) was used to identify Candida albicans. One
milliliter of healthy human blood serum was added to the
isolated yeasts, incubated at 37ºC and after 30, 60, 90 and
120 minutes the samples were examined under a micro-
scope to evaluate the creation of germ tube. Yeast capable
of forming a germ tube was considered positive. Results
were divided into two groups of Candida albicans and non-
albicans Candida spp.
3.1. Statistical Analysis
Data were analyzed using statistical package for social
sciences (SPSS) version 16 (SPSS Inc. Chicago, IL) for win-
dows. Chi-Square and Student-T-test were used. A P-value
< 0.05 was considered statistically significant.
4. Results
Eventually, 580 cases with the mean age of 30.42± 5.04
years underwent the analysis. Of the total 580 cases, vagi-
nal candidiasis was observed in 90 subjects. According to
the obtained results, prevalence of vaginal candidiasis was
15.5%. Candida albicans was observed in 92.3% of patients
with vaginal candidiasis. Also, results showed that 41.1%
of subjects used condoms and 26.6% used intrauterine de-
vices to prevent pregnancy.
5. Discussion
In the present study, the prevalence of vaginal candidi-
asis was reported 15.5%. It was also observed that 92.3% of
the subjects hadCandida albicans vaginitis versus 7.7% who
had non-albicans infection. It should be mentioned that
the current study evaluated the prevalence of vaginal can-
didiasis in some hospitals in Tehran, Iran, and reported the
rate of Candida albicans vaginitis; therefore, the prevalence
of vaginal candidiasis was so low in the recent study.
Gavgani et al. (8) reported the prevalence of vaginal
candidiasis as 25.2%. This rate was 15.5% in the current
study. According to Aalei et al. (10) the prevalence of vagi-
nal candidiasis was 19.8%. In the current study, the preva-
lence was lower than these two studies. It seems that the
prevalence of vaginal candidiasis is related to health, socio-
cultural factors and because of higher health and social
level in Tehran, the prevalence of vaginal candidiasis is
lower than other areas of the country.
Fouladvand et al. (11) showed that in 87.3% of subjects,
Candida albicans was the cause of vaginal candidiasis. This
finding confirmed the current study results.
Sobel et al. (12) concluded that Candida albicans was re-
sponsible for 80% - 92% of vulvovaginal candidiasis.
5.1. Conclusion
It was concluded that the prevalence of vaginal can-
didiasis was 15.5% in Tehran, Iran, and Candida albicans
was the most common pathogen in vaginal candidiasis.
Finally it was recommended that more studies should be
conducted on the factors of vaginitis in other regions with
health and cultural differences.
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